Immunocytochemical investigation of catalase and peroxisomal lipid β-oxidation enzymes in human hepatocellular tumors and liver cirrhosis

Virchows Archiv

Volumn 435, Issue 5, 1999, Pages 486-495

  Litwin, Jan A ^a   Beier, Konstantin ^b   Völkl, Alfred ^b   Hofmann, Walter J ^b   Fahimi, H Dariush ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hepatocellular tumors; Human; Immunocytochemistry; Peroxisomes

Indexed keywords

ANTIGEN; CATALASE; CELL PROTEIN; OXIDOREDUCTASE;

ANAPLASTIC CARCINOMA; ARTICLE; BIOGENESIS; CANCER GRADING; CLINICAL ARTICLE; FATTY ACID OXIDATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIPID OXIDATION; LIVER ADENOMA; LIVER CIRRHOSIS; LIVER TUMOR; PEROXISOME; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

3-HYDROXYACYL COA DEHYDROGENASES; ACETYL-COA C-ACYLTRANSFERASE; ACYL-COA OXIDASE; ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; CATALASE; ENOYL-COA HYDRATASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERASES; LIPID METABOLISM; LIVER CIRRHOSIS; LIVER NEOPLASMS; MULTIENZYME COMPLEXES; OXIDOREDUCTASES; PEROXISOMES;

EID: 0032754922     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050432     Document Type: Article

References (37)

1. 1. Alpert ME, Hutt MSR, Davidson CS (1969) Primary hepatoma in Uganda, a prospective clinical and epidemiologic study of forty-six patients. Am J Med 46:794-800
2. 2. Beier K, Völkl A, Fahimi HD (1992) Suppression of peroxisomal lipid β-oxidation enzymes by TNF-α. FEBS Letters 310:273-276
3. 3. Beier K, Völkl A, Fahimi HD (1997) TNF-α downregulates the peroxisome proliferator activated receptor-α and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Letters 412:385-387
4. 4. Bissel DM, Alpert ME (1972) The feedback control of hepatic cholesterol synthesis in Ugandan patients with liver disease. Cancer Res 32:149-152
5. 5. Blumenthal F, Brahn B (1910) Die Katalasewirkung in normaler und in carcinomatöser Leber. Z Krebsforsch 9:436-440
6. 6. Creemers J, Jardin JM (1968) Ultrastructure of a human hepatocellular carcinoma. J Microsc (Paris) 7:257-264
7. 7. De Craemer D, Kerckaert I, Roels F (1991) Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: A quantitative study. Hepatology 14:811-817
8. 8. De Craemer D, Pauwels M, Roels F (1993) Peroxisomes in cirrhosis of the human liver: a cytochemical, ultrastructural and quantitative study. Hepatology 17:404-410
9. 9. De Craemer D, Pauwels M, Hautekeete M, Roels F (1993) Alterations of hepatocellular peroxisomes in patients with cancer. Cancer 71:3851-3858
10. 10. De Craemer D, Roels F (1994) A peculiar distribution of peroxisomes in a patient with nodular regenerative hyperplasia of the liver. J Hepatol 20:394-397
11. 11. De Duve C, Baudhuin P (1966) Peroxisomes (Microbodies and related particles). Physiol Rev 46:323-357
12. 12. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
13. 13. Fahimi HD (1969) Cytochemical localization of catalase in rat hepatic microbodies (peroxisomes). J Cell Biol 43:275-288
14. 14. Greenstein JP (1954) Biochemistry of Cancer. 2nd edn Academic Press, New York
15. 15. Kampschmidt RF (1965) Mechanisms of liver catalase depression in tumor bearing animals: a review. Cancer Res 25:34-45
16. 16. Krisans SK (1996) Cell compartmentalization of cholesterol biosynthesis. Ann NY Acad Sci 804:142-164
17. 17. Lauer C, Völkl A, Riedel S, Fahimi HD, Beier K (1999) Impairment of peroxisomal biogenesis in human colon carcinoma. Carcinogenesis 20: 985-989
18. 18. Litwin JA, Völkl A, Müller-Höcker J, Hashimoto T, Fahimi HD (1987) Immuno-cytochemical demonstration of peroxisomal enzymes in human liver biopsies. Am J Pathol 128:141-150
19. 19. Litwin JA, Völkl A, Stachura J, Fahimi HD (1988) Detection of peroxisomes in human liver and kidney fixed with formalin and embedded in paraffin: the use of catalase and lipid β-oxidation enzymes as immunocytochemical markers. Histochem J 20:165-173
20. 20. Malick LE (1972) Ultrastructure of transplantable mouse hepatomas with different growth rates. J Natl Cancer Inst 49:1039-1055
21. 21. Masuda T, Beier K, Yamamoto K, Fahimi HD (1991) Peroxisomes in guinea pig liver: their peculiar morphological features may refelect certain aspects of lipoprotein metabolism in this species. Cell Tissue Res 263:145-154
22. 22. Mayer D, Metzger C, Leonetti P, Beier K, Benner A, Bannasch P (1998) Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer 29: 232-240
23. 23. Metzger C, Mayer D, Hoffman H, Bocker T, Hobe G, Benner A, Bannasch P (1995) Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 23:591-605
24. 24. Mochizuki Y, Hruban Z, Morris HP, Slesers A, Vigil EL (1971) Microbodies of Morris hepatomas. Cancer Res 31:763-773
25. 25. Ohnuma T, Maldia G, Holland JF (1966) Hepatic catalase activity in advanced human cancer. Cancer Res 26:1806-1818
26. 26. Ordonez NG, Mackay B (1983) Ultrastructure of liver cell and bile duct carcinomas. Ultrastruct Pathol 5:201-241
27. 27. Rao MS, Reddy JK (1996) Hepatocarcinogenesis of peroxisome proliferators. Ann NY Acad Sci 804:573-587
28. 28. Roels F, Pauwels M, Cornelis A, Kerckaert I, Van der Spek P, Goovaerts G, Versieck J, Goldfischer S (1983) Peroxisomes (microbodies) in human liver: cytochemical and quantitative studies of 85 biopsies. J Histochem Cytochem 31:235-237
29. 29. Ruebner BH, Gonzales-Licea A, Slusser RJ (1967) Electron microscopy of some human hepatomas. Gastroenterology 53:18-30
30. 30. Ryoo JW, Buschmann RJ (1989) Morphometry of liver parenchyma in needle biopsy specimens from patients with alcoholic liver disease: preliminary variables for the diagnosis and prognosis of cirrhosis. Mod Pathol 2:382-389
31. 31. Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, Endo H (1992) Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 12:2525-2533
32. 32. Schaff ZS, Lapis K, Safrany L (1970) The ultrastructure of primary hepatocellular cancer in man. Virch Arch A 352:340-358
33. 33. Schrader M, Burkhardt JK, Baumgart E, Lüers G, Spring H, Völkl A, Fahimi HD (1996) Interaction of microtubules with peroxisomes. Tubular and spherical peroxisomes in HepG2 cells and their alterations induced by microtubule-active drugs. Eur J Cell Biol 69:24-35
34. 34. Suto K, Kajihara-Kano H, Yokoyama Y, Hayakari M, Kimura J, Kumano T, Takahata T, Kudo H, Tsuchida S (1999) Decreased expression of the peroxisomal bifunctional enzyme and carbonyl reductase in human hepatocellular carcinomas. J Cancer Res Clin Oncol 125:83-88
35. 35. Thurman RG, Handler JA (1989) New perspectives in catalase-depedent ethanol metabolism. Drug Metab Rev 20:679-688
36. 36. Toker C, Trevino N (1966) Ultrastructure of a human primary hepatic carcinoma. Cancer 19:1594-1606
37. 37. Yokoyama Y, Tsuchida S, Hatayama I, Satoh K, Narita T, Rao MS, Reddy JK, Yamada J, Suga T, Sato K (1992) Loss of peroxisomal enzyme expression in preneoplastic and neoplastc lesions induced by peroxisome proliferators in rat liver. Carcinogenesis 13:265-269